The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world analysis of treatment patterns examining nab-Paclitaxel plus gemcitabine (nab-P+G) versus gemcitabine monotherapy (G) in first-line treatment of metastatic pancreatic adenocarcinoma (MPAC) in a U.S. community oncology setting.
 
Fadi S. Braiteh
Honoraria - Ambry Genetics; Amgen; BIND Biosciences; bioTheranostics; Caris Life Sciences; Foundation Medicine; Incyte; Insys Therapeutics; Ipsen; Lilly; Merrimack; MolecularHealth; Novartis; Novocure; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Ambry Genetics; Amgen; BIND Biosciences; bioTheranostics; Caris Life Sciences; Foundation Medicine; Incyte; Insys Therapeutics; Ipsen; Lilly; Merrimack; MolecularHealth; Novartis; Novocure; Pfizer; Roche/Genentech; Sanofi
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Genomic Health; Incyte; Insys Therapeutics; Ipsen; Lilly; Merck; Merrimack; Pfizer; Sanofi
 
Manish Patel
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Monika Parisi
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Quanhong Ni
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Si yeon Park
Employment - Celgene
 
Claudio Faria
Employment - Celgene
Stock and Other Ownership Interests - Celgene